Vital Signs - 3 July 2006


Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00


Be the first to review this product

This issue of Vital Signs, released on July 3, 2006, provides a strategic overview of the expanding role of in-vitro diagnostics with a special focus on molecular diagnostics and companion diagnostics. Additionally, an emerging company profile is provided on Target Discovery, an innovative personalized medicine company focused on the development of theranostic tests to guide treatment decisions. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of June 21 - June 26, 2006.

Table of Contents

Vital Signs - 3 July 2006The Expanding Role of IVD in U.S. HealthcareThe Expanding Role of IVD in U.S. Healthcare

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.